In the UK, this may include referral to a specialist weight management service or consideration of approved pharmacological treatments, in line with NICE guidance: Semaglutide (Wegovy) is recommended by NICE (TA875) for weight management in adults meeting defined BMI and comorbidity criteria, when used as part of a specialist weight management service
Esta hormona tiene varios efectos: Al combinar estos efectos, la semaglutida puede ser una poderosa herramienta para perder peso si se utiliza junto con una dieta y un estilo de vida saludables
in fact, poor tolerability was encountered in only 3.9% of patients, whereas 1.6% discontinued treatment due to treatment-related adverse events [46]
To put this in perspective, to justify their current valuation, they only have to grow their topline by ~7% for eight years while the overall obesity care market is expected to grow by ~26% CAGR
Neurosci Lett (2016) 612:1938